Chemoinformaics analysis of 2,3,5-Trimethylfuran
| Molecular Weight | 110.156 | nRot | 0 |
| Heavy Atom Molecular Weight | 100.076 | nRig | 12 |
| Exact Molecular Weight | 110.073 | nRing | 1 |
| Solubility: LogS | -5.759 | nHRing | 1 |
| Solubility: LogP | 5.097 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 1 | APOL | 19.1599 |
| nHD | 0 | BPOL | 11.7681 |
| QED | 0.558 |
| Synth | 4.25 |
| Natural Product Likeliness | 2.092 |
| NR-PPAR-gamma | 0.199 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.995 |
| Pgp-sub | 0.014 |
| HIA | 0.01 |
| CACO-2 | -4.581 |
| MDCK | 0.0000175 |
| BBB | 0.278 |
| PPB | 0.823364 |
| VDSS | 1.597 |
| FU | 0.1382 |
| CYP1A2-inh | 0.099 |
| CYP1A2-sub | 0.116 |
| CYP2c19-inh | 0.674 |
| CYP2c19-sub | 0.784 |
| CYP2c9-inh | 0.352 |
| CYP2c9-sub | 0.103 |
| CYP2d6-inh | 0.047 |
| CYP2d6-sub | 0.191 |
| CYP3a4-inh | 0.322 |
| CYP3a4-sub | 0.321 |
| CL | 14.135 |
| T12 | 0.026 |
| hERG | 0.003 |
| Ames | 0.08 |
| ROA | 0.475 |
| SkinSen | 0.202 |
| Carcinogencity | 0.037 |
| EI | 0.021 |
| Respiratory | 0.948 |
| NR-Aromatase | 0.035 |
| Antiviral | No |
| Prediction | 0.932909 |